Skip to main navigation Skip to search Skip to main content

Simple cardiovascular risk stratification by replacing total serum cholesterol with anthropometric measures: The MORGAM prospective cohort project

  • Victoria Rosberg
  • , Julie KK Vishram-Nielsen*
  • , Anna M.Dyrvig Kristensen
  • , Manan Pareek
  • , Thomas S.G. Sehested
  • , Peter M. Nilsson
  • , Allan Linneberg
  • , Luigi Palmieri
  • , Simona Giampaoli
  • , Chiara Donfrancesco
  • , Frank Kee
  • , Giuseppe Mancia
  • , Giancarlo Cesana
  • , Giovanni Veronesi
  • , Guido Grassi
  • , Kari Kuulasmaa
  • , Veikko Salomaa
  • , Tarja Palosaari
  • , Susana Sans
  • , Jean Ferrieres
  • Jean Dallongeville, Stefan Söderberg, Marie Moitry, Wojciech Drygas, Abdonas Tamosiunas, Annette Peters, Hermann Brenner, Ben Schöttker, Sameline Grimsgaard, Tor Biering-Sørensen, Michael H. Olsen
*Corresponding author for this work
  • ​Nordsjællands Hospital
  • University of Copenhagen
  • Zealand University Hospital, Roskilde
  • Lund University
  • Istituto Superiore di Sanità - National Center for Epidemiology, Surveillance and Health Promotion
  • Queen's University Belfast
  • University of Milano-Bicocca
  • University of Insubria
  • National Institute for Health and Welfare
  • Catalan Department of Health
  • Institut Pasteur de Lille
  • Umeå University
  • University Hospitals of Strasbourg
  • Heidelberg University
  • German Cancer Research Center
  • UiT The Arctic University of Norway
  • Copenhagen University Hospital
  • Bispebjerg and Frederiksberg Hospitals
  • Yale New Haven Hospital
  • University of Toulouse
  • National Institute of Cardiology, Warsaw, Poland.
  • Lithuanian University of Health Sciences
  • Institute of Human Genetics, Helmholtz Zentrum München
  • Steno Diabetes Center Sjaelland, Akacievej 7, DK-4300, Holbaek, Denmark.

Research output: Contribution to journal › Journal article › Research › peer-review

96 Downloads (Pure)

Abstract

To assess whether anthropometric measures (body mass index [BMI], waist-hip ratio [WHR], and estimated fat mass [EFM]) are independently associated with major adverse cardiovascular events (MACE), and to assess their added prognostic value compared with serum total-cholesterol. The study population comprised 109,509 individuals (53% men) from the MORGAM-Project, aged 19–97 years, without established cardiovascular disease, and not on antihypertensive treatment. While BMI was reported in all, WHR and EFM were reported in ∼52,000 participants. Prognostic importance of anthropometric measurements and total-cholesterol was evaluated using adjusted Cox proportional-hazards regression, logistic regression, area under the receiver-operating-characteristic curve (AUCROC), and net reclassification improvement (NRI). The primary endpoint was MACE, a composite of stroke, myocardial infarction, or death from coronary heart disease. Age interacted significantly with anthropometric measures and total-cholesterol on MACE (P ≤ 0.003), and therefore age-stratified analyses (<50 versus ≥ 50 years) were performed. BMI, WHR, EFM, and total-cholesterol were independently associated with MACE (P ≤ 0.003) and resulted in significantly positive NRI when added to age, sex, smoking status, and systolic blood pressure. Only total-cholesterol increased discrimination ability (AUCROC difference; P < 0.001). In subjects < 50 years, the prediction model with total-cholesterol was superior to the model including BMI, but not superior to models containing WHR or EFM, while in those ≥ 50 years, the model with total-cholesterol was superior to all models containing anthropometric variables, whether assessed individually or combined. We found a potential role for replacing total-cholesterol with anthropometric measures for MACE-prediction among individuals < 50 years when laboratory measurements are unavailable, but not among those ≥ 50 years.

Original languageEnglish
Article number101700
JournalPreventive Medicine Reports
Volume26
Number of pages9
ISSN2211-3355
DOIs
Publication statusPublished - Apr 2022

Bibliographical note

Publisher Copyright:
© 2022 The Author(s)

Funding

The MORGAM Project has received funding from EU projects MORGAM (Biomed, BMH4-CT98-3183), GenomEUtwin (FP5, QLG2-CT-2002-01254), ENGAGE (FP7, HEALTH-F4-2007-201413), CHANCES (FP7, HEALTH-F3-2010-242244), BiomarCaRE (FP7, HEALTH-F2-2011-278913), euCanSHare (Horizon 2020, No. 825903) and AFFECT-EU (Horizon 2020, No. 847770); and Medical Research Council, London (G0601463, No. 80983: Biomarkers in the MORGAM Populations). This has supported central coordination, workshops and part of the activities of the MORGAM Data Centre, the MORGAM Laboratories and the MORGAM Participating Centres. VS was supported by the Finnish Foundation for Cardiovascular Research. SSg was supported by the Swedish Heart and Lung foundation and by the County council of V?stertbotten. MP has the followings relationships ? Advisory Board and Speaking Honoraria: AstraZeneca; Speaking Honoraria: Bayer, Boehringer Ingelheim.

Keywords

  • Adipose tissue
  • Assessment, risk
  • Body mass index
  • Cardiovascular diseases
  • Cholesterol
  • Waist-hip ratio

Fingerprint

Dive into the research topics of 'Simple cardiovascular risk stratification by replacing total serum cholesterol with anthropometric measures: The MORGAM prospective cohort project'. Together they form a unique fingerprint.

Cite this